Wealth Enhancement Advisory Services’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.64M Buy
17,362
+2,391
+16% +$1.19M 0.01% 761
2025
Q4
$7.62M Buy
14,971
+8,278
+124% +$3.86M 0.01% 807
2025
Q3
$3.06M Buy
6,693
+609
+10% +$205K ﹤0.01% 1202
2025
Q2
$1.79M Buy
6,084
+2,655
+77% +$793K ﹤0.01% 1409
2025
Q1
$1.06M Sell
3,429
-2,214
-39% -$759K ﹤0.01% 1570
2024
Q4
$1.99M Buy
5,643
+769
+16% +$283K ﹤0.01% 1198
2024
Q3
$1.75M Buy
4,874
+2,208
+83% +$746K ﹤0.01% 1125
2024
Q2
$849K Buy
2,666
+81
+3% +$21.4K ﹤0.01% 1356
2024
Q1
$594K Buy
2,585
+1,191
+85% +$269K ﹤0.01% 1480
2023
Q4
$307K Buy
1,394
+149
+12% +$34.3K ﹤0.01% 1796
2023
Q3
$281K Buy
+1,245
New +$287K ﹤0.01% 1780

Other funds holding UTHR